Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2003
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162757 Topically administering estrogen receptor antagonists
08/28/2003US20030162748 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen
08/28/2003US20030162744 Salmon-origin chondroitin sulfate
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161895 Comprising water, Xanthan gum, Magnesium aluminum silicate, Kaolin, Silicon dioxide, Sodium sulfacetamide, Sodium thiosulfate, Glyceryl stearate, PEG-100 Stearate, Quillaia saponaria extract, Benzyl alcohol, sulfur, high sorption base
08/28/2003US20030161883 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003US20030161850 Agent for inhibiting adhesion of the pathogenic flora of the skin
08/28/2003US20030161832 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161821 Pharmaceutical composition
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161815 Cell delivery system
08/28/2003US20030161811 Method for treating cervical cancer
08/28/2003US20030161802 Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds
08/28/2003US20030161797 Method of reducing and treating UVB-induced immunosuppression
08/28/2003US20030161793 UV-photostabilized sunscreen compositions comprising dibenzoylmethane/benzophenone compounds
08/28/2003US20030159914 Plant extracts from fruit pits; presoaking in water, distillation; separation by specific gravity; bactericides, antiseptics; sterilization
08/28/2003DE29924428U1 New topical composition for treating herpes family viruses, reduces treatment-related erythema but maintains high activity
08/28/2003CA2512020A1 Compositions and methods for delivery of skin cosmeceuticals
08/28/2003CA2486381A1 Lipase inhibiting composition
08/28/2003CA2477191A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003CA2477117A1 Pyrrolopyrimidine derivative
08/28/2003CA2477116A1 Pyrrolopyrimidine derivatives
08/28/2003CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476837A1 Sodium channel blockers
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476438A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476402A1 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2463438A1 Antipruritics
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1338283A1 Use of neoruscine to treat alopecia
08/27/2003EP1338269A1 Composition for whitening the skin and alleviating of pigmentation disorders containing creatinine and/or a creatinine derivative as active ingredient
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337540A2 Motilide compounds
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003EP1337268A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337248A1 Methods for treatment of inflammatory diseases
08/27/2003EP1337235A1 Cosmetic method of treating skin
08/27/2003EP1337234A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
08/27/2003EP1337233A1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling
08/27/2003EP1337220A2 Compositions having comfrey and methods for reducing retinoid-induced skin irritation
08/27/2003EP1152748B1 Method and composition for treating acne
08/27/2003EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
08/27/2003EP0906089B1 Buccal delivery system
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0735881B1 Means and method for hormonal contraception and/or the treatment of acne
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438994A Polymorphic forms/hydrates of N-[4-(3-chloro-4-fluoro-phenylamino)-7- (3-morpholin-4-ylpropoxy)-quinazolin-6-Yl] acrylamide dihydrochloride
08/27/2003CN1438992A Biocidal polymers based on guanidine salts
08/27/2003CN1438895A Peptide composition
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438004A Method for making medicine without ache while injection
08/27/2003CN1437970A Medicine composition for recovering youth and nourishing face and preparation method
08/27/2003CN1437931A Coenzyme Q10 precursor liposome and preparation method
08/27/2003CN1437928A Alose itching-stopping skin-care cream
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119334C Substsituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease charaterized by abnomal cell proliferation
08/27/2003CN1119172C Chitosan/gelatin network modification on surface of aliphatic polyester
08/27/2003CN1119162C Dermatitis ointment and its preparing process
08/27/2003CN1119160C Ointment for curing skin trauma and its preparing method
08/27/2003CN1119155C Chinese medicine composition for treating damaged skin
08/27/2003CN1119143C Supermicron pearl talcum powder and its preparation process
08/27/2003CN1119142C Supermicron pearl face cream and its preparation process
08/26/2003US6610890 Treatment and/or prevention of diabetic complications; such as 3,3',4,4',5,5'-hexabromo-2,2'-dihydroxy-oxydiphenyl
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 1065